# Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia

> **NCT04001023** · NA · UNKNOWN · sponsor: **Turku University Hospital** · enrollment: 40 (estimated)

## Conditions studied

- Epithelial Ovarian Cancer
- Fallopian Tube Cancer
- Peritoneal Carcinoma
- Hypoxia

## Interventions

- **DEVICE:** Imaging with 18F-EF5 PET/CT

## Key facts

- **NCT ID:** NCT04001023
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-09
- **Primary completion:** 2022-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2019-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04001023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04001023, "Overcoming Chemoresistance in Advanced Ovarian Cancer Via Targeting Hypoxia". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT04001023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*